Biomarkers relative to NSCLC prediction and prognosis have been reported, such as the epidermal growth factor receptor (EGFR)-related biomarkers (EGFR, Ki-67, pAKT and p27) (2–9). This evidence concerns the gene EGFR and non-small cell lung carcinoma.